ROSEN, LEADING TRIAL ATTORNEYS, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK

<p>NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline. SO WHAT: If you […]</p>
<p>The post <a href="https://forextv.com/top-news/rosen-leading-trial-attorneys-encourages-outlook-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-otlk/">ROSEN, LEADING TRIAL ATTORNEYS, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>